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Abstract
Telocytes are emerging cell population localized in the stroma of numerous organs, characterized by a distinc-
tive morphology – small cell body with very long, slender prolongations, termed telopodes. Those cells can 
be found in the whole female reproductive system: in the vagina, uterus, oviducts and ovaries, mammary 
glands and also in the placenta. In our review, we aim at complete and transparent revision of the current 
knowledge of telocytes’ localization and function, enriched by the analysis of the possible future direction 
of development of their clinical applications. The function of telocytes in the reproductive system has not been 
fully elucidated yet; however, many researchers point at their role in the regulation of local microenviron-
ment, myogenic contractile mechanism, bioelectrical signaling, immunomodulation and regulation of blood 
flow. Additionally, previous research suggests that telocytes might act as sex hormone level sensors and 
are connected with pregnancy maintenance. As the morphology and number of those cells change under 
pathological conditions, such as pre-eclampsia, endometriosis and ovarian failure, there is a chance that 
they may contribute to therapy of abovementioned conditions. The impact of telocytes on stem cells and 
angiogenesis has been proven in many organs, and may be useful in regenerative medicine of the female 
reproductive system. A recently found connection between the proliferation rate of breast cancer cells and 
stromal cells like telocytes might be a step forward to the management of mammary gland neoplasms.
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Introduction
Definition
Telocytes (TCs) are a new type of cells located in the 
stroma of several organs. Their most characteristic feature 
is the presence of extraordinarily long, slight prolongations 
called telopodes (Tps).1 As far as the female reproductive 
system is concerned, TCs were described in the mammary 
gland, vagina, uterus, uterine tube, and placenta.2–6
A brief history
The history of TCs derives from Interstitial Cajal Cells 
(ICCs) discovered by the Spanish neuroanatomist and Nobel 
Prize winner Santiago Ramon y Cajal. In 1889, Cajal found 
a new type of cells located within the muscle layer of the 
intestine, between nerve ganglia and smooth muscle cells.1
About a half a century later, Faussone-Pellegrini et al. 
proved the existence of cells similar to ICCs in the gas-
trointestinal tract with the use of electron microscopy.7 
In 2005, Popescu et al. found interstitial cells resembling 
ICCs in the specimens from a mammary gland.2 They 
called them Interstitial Cajal-like Cells (ICLCs). A  re-
examination of the muscular coat of the gut performed 
by Pieri et al. showed that ICLCs are functionally and 
morphologically different from ICCs.8 As a result of these 
studies, in 2010 Popescu suggested that the name “Inter-
stitial Cajal-like Cells” should be changed to “Telocytes” 
to clearly distinguish these 2 cell populations.
In the female reproductive system, TCs were first de-
scribed in  2005, and they were found within the wall 
of the uterus.4,9 Further research proved their existence 
also in the vagina, uterine tubes and placenta (Fig. 1).3,6,10
The name “Telocytes” derives from ancient Greek – the 
word “telos” refers the object of huge potential.11 Nowa-
days, thanks to  TCs’ morphology and functions, they 
arouse huge interest among researchers as potential con-
tributors to intercellular communication, cancerogenesis 
and a target for regenerative medicine purposes.12–14 In our 
review, we are trying to summarize the current knowledge 
of tissue distribution, identification methods and potential 
functions of TCs in female reproductive system.
General aspects of telocytes
Cell phenotype
TCs are small cells with 1–5 long and thin prolongations 
named telopodes (Tps).11 The cell body is rather small, its 
average length oscillates around 9.39 ±3.26 μm. It contains 
big, heterochromatic nucleus and a thin, perinuclear rim 
of cytoplasm including few organelles, mainly mitochon-
dria.11,15 The shape of the cell body is influenced by the 
actual number of Tps, ranging from piriform, through 
spindle and triangular to stellate.16 Tps are up to 1000 μm 
long, which makes them one of the longest structures in the 
body, except for some axons.15,17 As they are composed 
of dilated segments, named podoms, and thin podomeres, 
their shape is termed as moniliform.15,16 Podoms contain 
organelles responsible for protein synthesis and intercel-
lular signaling, namely rough and smooth endoplasmic re-
ticulum, Golgi apparatus, mitochondria, and caveolae.12,16 
Considering the small size of TCs’ body and even more 
narrow Tps (around 0.5 μm wide podoms), it would be ut-
terly difficult to distinguish them from other cells in light 
microscopy, thus the golden standard for identifying TCs 
is transmission electron microscopy (TEM).16,18
Localization
Until now, TCs have been identified in the female repro-
ductive system, placenta, mammary gland, cardiovascular 
system, urinary system, gastrointestinal tract, liver and 
pancreas, trachea, lungs and pleura, spleen, bone marrow, 
dura mater, choroid plexus, meninges, trigeminal ganglion, 
testicles and prostate, skin, skeletal muscles, and eyes.16,19
Fig. 1. A timeline of key discoveries 
in telocytes’ research
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Cell immunophenotype
Since numerous cells, for instance fibroblasts, neurons 
or pericytes, have a morphology closely resembling that 
of telocyte, it became apparent that there is a need for 
finding specific markers for TCs. Until now, TCs have 
been confirmed for expression of CD34, c-Kit, vimentin, 
PDGFR-α and -β, caveolin-1, CD44, Sca-1, Nanog and 
Oct4.16,17,20
Nevertheless, those markers are not perfect. There are 
a lot of discrepancies between studies in terms of CD34 
and c-Kit expression in TCs in different tissues. From all 
abovementioned markers, CD34 is considered as the most 
reliable for TCs, although Suciu et al. reported that only 
70% of the cells in the placenta, which have TC’s mor-
phology, express CD34.20,21 Moreover, the second most 
frequently used marker, c-Kit, is not expressed by TCs 
in gastrointestinal tract.22 That inconsistency might be 
caused by imperfections in technical procedures or the 
existence of tissue-specific subtypes of TCs.18,21 Another 
difficulty is connected with the expression of those mark-
ers in cells with similar morphology – CD34 is expressed 
by endoneurial fibroblasts, while vimentin together with 
PDGFR-β are present in fibroblasts, pericytes and neu-
rons.18 In order to minimize the risk of misidentification, 
at least double immunofluorescence staining should be 
used in order to detect TCs. All things considered, a uni-
versal marker for TCs should be found – expressed in every 
tissue and characteristic only for them.
Intercellular communication
TCs establish both homo- and heterocellular junctions 
together with connections with extracellular matrix.20 
Moreover, they also communicate through extracel-
lular vesicles, which is a  form of  juxtacrine/paracrine 
signaling.23
Homocellular junctions are formed between 2 Tps 
or between Tps and TC’s body.24 In most cases, they are 
connected by simple apposition of 2 plasma membranes, 
but there also exist more complex forms of linkage – punc-
ta adhaerentia minima, processus adhaerens, recessus 
adhaerens, and manubria adhaerentiva. Their primary 
function is to maintain the integrity of 3-dimensional 
network of TCs during changes of shape of the tissue. 
Second presumptive function is  linked with catenins, 
which are important components of adherens junctions, 
as they might play role in mechanosensing. The last type 
of homocellular contact is gap junction (nexus), which 
allows the exchange of ions and small molecules between 
adjacent cells.20
Heterocellular junctions typically have the morphology 
of point contacts, nanocontacts, planar contacts or simple 
apposition of plasma membranes.20 TCs are connected 
through them with fibroblasts, myofibroblasts, pericytes, 
endothelial cell, neurons, stem cells, macrophages, mast 
cells, lymphocytes, plasma cells, Schwann cells, cardio-
myocytes and smooth muscle cells.16,21,24,25 Distinctive type 
of heterocellular junctions is stromal synapse, which links 
TCs with immune cells and cardiac stem cells.24,26
Extracellular vesicles shedded by TCs can be divided into 
3 groups: exosomes (from endosomes), ectosomes (from 
plasma membrane) and multivesicular cargo (multiple, 
tightly packed endomembrane-derived vesicles).23 Vesicles 
mainly contain proteins, lipids, miRNAs, mRNAs, and 
mtDNA.12 Hence, they are crucial for intercellular signal-
ing and they even might be connected with a modifica-
tion of the post-transcriptional activity of recipient cells.27 
Fibronexuses and focal adhesions were found between TCs 
and components of extracellular matrix.20
Electrophysiological properties 
of telocytes
Since TCs form an abundant network interconnecting 
numerous types of cells in the interstitium, a hypothesis 
was postulated that TCs may be involved in bioelectrical 
signaling. Thus far, it has been confirmed that TCs ex-
press: T-type calcium channels (Cav3.1 and Cav3.2), small-
conductance calcium-activated potassium channels (SK3), 
large-conductance calcium-activated potassium channels 
(BKCa), inwardly rectifying potassium channels (IKir) and 
calcium-dependent hyperpolarisation-activated chloride 
inward channels.28,29,30,31
L-type calcium channels, transient outward potassium 
channels (Ito) and ATP-sensitive potassium channels (KATP) 
were not detected in TCs in previous studies.30,31
Physiological functions  
of telocytes
At the present moment, TCs are considered as cells with 
a rather mysterious function, as there is still a lack of direct 
evidence for their actual properties. The most frequently 
proposed one is connected with their role in intercellular 
signaling – they might be responsible for the integration 
of signals from numerous systems (for instance nervous, 
vascular, and immune), regulation of tissue homeostasis 
and long distance communication including bioelectri-
cal signaling.16,32 Secondly, since it is proven that TCs are 
located in close proximity to stem cells, they may be cru-
cial for tissue regeneration and repair.33 Moreover, TCs 
build a scaffold, which probably enables the maintenance 
of proper organization of extracellular matrix and cell mi-
gration, also during organogenesis process.34,35 Addition-
ally, TCs presumably have angiogenic properties thanks 
to vascular endothelial growth factor (VEGF) expression 
and they may be vital to anti-oxidative protection, as they 
are abundant in  mitochondrial superoxide dismutase 
(SOD2).36,37
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Telocytes  
in female reproductive system
Telocytes in vagina
Proto-oncogene c-Kit positive cells with long processes, 
which nowadays might be classified as TCs, were found 
in muscular layer of the human vagina. Shafik et al. sug-
gested their potential role in generating slow waves re-
sulting in the contractility of smooth muscle cells in the 
vagina.3 However, their presence and role in that organ 
should be thoroughly assessed in the future.
Telocytes in uterus
In the human uterus, TCs were observed in the inter-
stitial space of the endometrium and myometrium.38,39 
Endometrial TCs were detected in the stroma of the stra-
tum functionalis and stratum basalis around the endome-
trial glands, while myometrial TCs form a 3-dimensional 
network intermingling with smooth muscle bundles.1,38 
That location in the myometrium may suggest that TCs 
might be involved in myogenic contractile mechanism 
during sperm transport prior to fertilization, embryo im-
plantation and delivery.1
The quantity of TCs in the endometrium and the myo-
metrium correlates with the reproductive state.40 Imma-
ture rat uteruses present the lowest density of TCs com-
pared to pregnant and postpartum ones.41 The number 
of  endometrial TCs in pregnant state increases, while 
there is a reduction of their number in the myometrium.40 
Hence, changes in the quantity of TCs in the myometrium 
may be associated with the prevention of preterm deliv-
ery.25 Moreover, the highest number of myometrial TCs 
were found in the postpartum uteri, which may be related 
with its involution.40
Additionally, the morphology of Tps is different in preg-
nant and non-pregnant myometrium – in non-pregnant 
uterus podomers are wider and podoms are thinner com-
pared to pregnant ones (Table 1).31
The most useful markers used for the identification 
of TCs in the uterus are CD34 and PDGFR-α/PDGFR-β 
in double immunolabelling.25 PDGFR-α/β is mostly ex-
pressed at TC’s cell body, while Tps are intensely positive for 
CD34.28 TCs in uterus are also positive for α-SMA, CD44, 
vimentin, Sca-1, and c-Kit.41 Nevertheless, the expression of  
c-Kit here is questionable. Yang et al. detected various types 
of TCs in uterine samples: c-Kit(–)/vimentin(+), c-Kit(+)/
vimentin(+) and c-Kit(+)/CD34(+). As a consequence, they 
suggested the presence of various subpopulations of TCs 
in uterus which may perform disparate functions.42
The comparison of markers applicable to the detection 
of TCs in female reproductive system is shown in Table 2. 
TCs also express connexin43, a gap junction protein which 
might play an essential role in decidua maturation. A de-
crease in the expression of that protein is linked with re-
current pregnancy loss.41,43
Furthermore, the expression of estrogen receptor alpha 
(ERα) and progesterone receptor A (PR-A) were confirmed 
on the surface of uterine TCs.44 This suggests that TCs 
may be the sensors of sex hormone levels. TCs also express 
these receptors in uterine tubes and upper lamina propria 
of the human urinary tract.45,46
Additionally, human uterine TCs express 2 types 
of channels at their cell membrane: T-type calcium chan-
nels (Cav3.1, Cav3.2) and small-conductance calcium-ac-
tivated potassium channels (SK3).25
The presence of Cav3.1 and Cav3.2 channels were con-
firmed both in  cell body and Tps of  TCs. Expression 
of Cav3.1 and Cav3.2 channels correlates with the reproduc-
tive state: Cav3.1 expression in pregnant and non-pregnant 
Table 1. The variation in morphology of Tps and extracellular vesicles 
between non-pregnant and pregnant myometrium31
Parameter Non-pregnant myometrium
Pregnant 
myometrium
Podom thickness [nm] 268.6 ±8.27 316.38 ±17.56
Podomer gauge [nm] 81.94 ±1.77 75.53 ±1.81
Number of exosomes/
shedded microvesicles
26/89 20/168
Diameter of extracellular 
vesicles [nm]
58–405
average 151
65–362
average 170
Table 2. Expression of markers on TCs in individual parts of female reproductive system
Organ
Marker
CD34 c-kit vimentin PDGFR-α PDGFR-β ERα PR-A Additional markers
Vagina n/d + n/d n/d n/d n/d n/d n/d
Uterus + +/– + + + + +
α-SMA
CD44
Sca-1
Uterine tubes + – + n/d n/d + + n/d
Ovaries + n/d + + + n/d n/d n/d
Mammary gland + +/– + n/d n/d n/d n/d CD10
Placenta + + + n/d n/d n/d n/d caveolin1
ERα – estrogen receptor α; PR-A – progesterone receptor A; n/d – no data.
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state is equal, while Cav3.2 channels are mostly detected 
in pregnant myometrium.25 Moreover, in non-pregnant 
state Cav3.1 were strongly expressed in Tps, while Cav3.2 
were observed only in cell body. The differences in expres-
sion of these channels suggest that TCs may play role in de-
tection of mechanical stretching of the pregnant uterus.28
SK3 channels were observed in the uterus of several spe-
cies (for instance in human, mice or rat). Their expression 
is also correlated with pregnant or non-pregnant state. 
The density of SK3 channels in non-pregnant myometrium 
is elevated where they are present on TCs and vascular 
endothelium, in contrast to pregnant state with decreased 
number of channels, which are only located on vascular 
endothelium.47 Downregulation of SK3 channels during 
pregnancy probably reduce contractility of  the uterus. 
Changes in the expression of SK3 channels could also be 
caused by different stage of the hormonal cycle (expres-
sion of channels influenced by sex hormones) or diseases 
connected with hormonal imbalance.29
Uterine TCs create connections with other cells and 
components of extracellular matrix (for instance collagen 
or elastic fibres). Heterocellular junctions between TCs 
and smooth muscle cells, nerve endings and blood vessels 
were additionally observed.48 TCs in uterus can also com-
municate by shedding membrane microvesicles: exosomes 
and ectosomes. No differences were noticed in number 
and diameter of shedded vesicles in pregnant myometrium 
compared with non-pregnant (Table 1).25 Moreover, Diaz-
Flores et al. proved that TCs have endocytic properties, 
which suggest existence of bidirectional information ex-
change between TCs and neighbouring cells.49
Additionally, TCs establish contacts with immune cells, 
namely lymphocytes, eosinophils, basophils, plasma cells, 
and macrophages.38 Chi et al. confirmed that TCs are able 
to  activate peritoneal macrophages, which may result 
in  increased amount of IL-6, IL-10, IL1R1, TNF-α and 
iNOS. Pathologically high levels of these proteins could 
lead to implantation failure, immunologically-mediated 
abortion or endometriosis.50
TCs may also be useful in uterine regenerative medicine. 
Recent studies revealed that TCs from pregnant and non-
pregnant myometrium have different reactivity to low-level 
laser stimulation (LSSS). Tps from pregnant uterus are more 
susceptible to extension after using LSSS compared to Tps 
from non-pregnant uterus. These differences are probably 
caused by variations in TCs’ cytoskeleton structure (up-reg-
ulation of integrins) in pregnant and non-pregnant state.51
Telocytes in uterine tubes
TCs are located in lamina propria and muscular layer 
of uterine tubes. Their Tps create a 3-dimensional net-
work between smooth muscle cells (SMCs), nerve end-
ings and blood vessels. Close relations between TCs and 
SMCs may suggest that TCs participate in uterine tube 
contractility.52
TCs in the uterine tube present a typical cell phenotype. 
They shed 3 types of extracellular vesicles: exosomes (di-
ameters: 60–100 nm), ectosomes (100–250 nm) and mi-
crovesicles (250–350 nm).52 Similarly to the uterus, they 
express on their surface PR-A and ERα receptors, which 
might be connected with the control of peristaltic move-
ments in the uterine tube due to changes in estrogen (ac-
celeration of contractions) and progesterone (deceleration 
of contractions) levels.1
TCs are connected with other cells located in the uter-
ine tubes tissue. Heterocellular junctions with fibrocytes, 
pericytes, SMCs, nerve endings, mast cells and stem cells 
were observed.42 Yang et al. claimed that Tps are located 
in close vicinity to lymphocytes and plasma cells, which, 
according to their study, may suggest that TCs are involved 
in the stimulation of plasma cells to antibodies synthesis. 
However, the aforementioned property requires further 
investigation.53
Yang et al. proved that TCs’ quantity and ultrastructure 
dramatically change in rat model of acute salpingitis. TCs 
retrieved from salpingitis-affected uterine tubes presented 
numerous abnormalities, such as: loss of organelles, cy-
toplasmic vacuolization, dilatation of rough endoplasmic 
reticulum and loss of  intercellular junctions. Addition-
ally, the number of TCs was significantly decreased.53 
The declined quantity of TCs, which is probably caused 
by the overproduction of iNOS, COX-2, LPO and estra-
diol, damages those cells and were also observed in pelvic 
endometriosis and tubal ectopic pregnancy.40,42,54 Never-
theless, TCs of nearly normal appearance can be found 
even in endometriosis-affected uterine tube. Presumably, 
that is the reason why some women in this state have only 
reduced fertility instead of complete infertility.42
Telocytes in ovary
TCs were detected in the stroma of mice ovaries and 
they were positive for CD34, vimentin, PDGFR-α and -β. 
Thus far, the function of TCs in ovaries has not been deter-
mined; however, there is an assumption that they might be 
responsible for maintaining the local microenvironment.55
Liu et al. found statistically a significant decrease in the 
number of TCs in ovaries affected by cyclophosphamide-
induced premature failure compared to  healthy con-
trols. As a consequence, they might be used as a mark-
er of declining ovarian functions caused by the intake 
of cyclophosphamide.55
Telocytes in mammary gland
The existence of TCs in the mammary gland was con-
firmed in 2005 and they present morphology which is typi-
cal for them. They form a network of inactive mammary 
gland in the stroma, mainly in the interlobular space and 
also in the interlobular area, though in very small quan-
tities. TCs closely encompass capillaries and mammary 
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gland ducts, predominantly by their Tps located perpen-
dicularly to long axes of those structures.56
In mammary gland, TCs are positive for CD34 and vi-
mentin.57 However, there is an incongruity between the 
studies in terms of expression of c-kit – Gherghiceanu et al. 
along with Mou et al. confirmed the presence of that mark-
er, while Petre et al. negated its expression.56–58 Addition-
ally, TCs in mammary gland might be partially positive 
for CD10.58
TCs are connected by stromal synapses with stromal 
immune cells, such as plasma cells, lymphocytes, mast 
cells and macrophages. Contacts with fibroblasts were also 
observed.56 The direct link between TCs and endothelial 
cells or pericytes have not been found.13
Apart from the possible involvement of TCs in the or-
ganization of properly functioning structure of mammary 
gland, they may play an important role in the modulation 
of an immune system, thanks to their connections with 
immune cells.56
As accurate arrangement of stroma has a beneficial effect 
on maintaining local microenvironment, any alterations 
in the function of TCs’ network may lead to an increase 
in the risk of neoplastic process in the tissue.13 Mou et al. 
investigated the influence of TCs and other stromal cells 
on the growth dynamic of breast cancer.57 They observed 
that TCs establish membrane-to-membrane connections 
with breast cancer cells in co-culture and presumably par-
ticipate in the formation of neoplastic cell clusters. There 
was an increase in the proliferation index and a reduction 
in the apoptosis ratio among breast cancer cells accompa-
nied by stromal cells, compared to isolated breast cancer 
cell culture.57 Furthermore, the number of heterocellular 
junctions formed by TCs is diminished in neoplastic tis-
sue.13 Summing up, TCs along with other stromal cells 
may contribute to neoplasm development and survival.57 
As a consequence, TCs might emerge as a novel target 
in breast cancer therapy.
Telocytes in placenta
Placental TCs were detected by Suciu et al. in the large 
and peripheral stem villi, where they are located just be-
neath the trophoblast. Their Tps are orientated parallelly 
to the basement membrane and circularly or longitudinally 
to blood vessels.21,40 They are positive here for: c-kit, CD34, 
vimentin, caveolin1, VEGF and iNOS.25
TCs create heterocellular contacts with mast cells, myo-
fibroblasts, SMCs and specific placental macrophages, 
called Hofbauer cells (HBCs).25 However, the function 
of TCs in human term placenta is still unknown. The pres-
ence of junctions between TCs and HBCs suggest their 
possible contribution to immune surveillance. Consid-
ering the fact that placenta is not an innervated organ, 
Bosco et al. suggested that TCs may be crucial for signal 
transduction resulting in blood flow in foetal vessels and 
aetiopathogenesis of pre-eclampsia.59
Conclusions
TCs are a unique cell population, located in the stroma 
of numerous organs, also in the female reproductive sys-
tem. Their role specific for that system can be connected 
with their involvement in muscular layer contractility, 
pregnancy maintenance, immunomodulation and tissue 
regeneration. Alterations of their number in the female re-
productive system might be connected with pre-eclampsia, 
endometriosis or acute salpingitis and further research 
on that subject may lead to a turning point in TCs-related 
treatment of those conditions.
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